Cvs Health Corp Stock Price To Book

CVS Stock

USD 56.71 0.12 0.21%

CVS Health Corp fundamentals help investors to digest information that contributes to CVS Health's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Health stock.

Short Long Term Debt Total Total Assets

Price To Book Ratio is likely to drop to 1.26 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CVS Health Corp Company Price To Book Analysis

CVS Health's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current CVS Health Price To Book

0.95 X

Most of CVS Health's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CVS Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for CVS Health is extremely important. It helps to project a fair market value of CVS Stock properly, considering its historical fundamentals such as Price To Book. Since CVS Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CVS Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CVS Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Good Will	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.97	0.97	0.91	0.94	1.0	0.98	0.83	0.95	0.94	0.96	0.99	0.95	-0.58	0.57	0.58	0.97	0.19	0.87	0.79	0.62	0.67	0.81	0.96	0.96	-0.82	0.72
Total Stockholder Equity	0.97		0.89	0.94	0.93	0.94	0.97	0.78	0.9	0.94	0.89	0.96	0.87	-0.6	0.53	0.66	0.91	0.24	0.77	0.78	0.53	0.61	0.8	0.88	0.9	-0.81	0.72
Net Debt	0.97	0.89		0.83	0.85	0.98	0.91	0.84	0.98	0.84	0.96	0.97	0.98	-0.55	0.65	0.53	0.95	-0.01	0.93	0.75	0.75	0.73	0.69	0.97	0.93	-0.73	0.6
Retained Earnings	0.91	0.94	0.83		0.95	0.89	0.96	0.8	0.82	0.99	0.78	0.92	0.82	-0.79	0.46	0.66	0.81	0.31	0.69	0.88	0.38	0.67	0.77	0.77	0.79	-0.78	0.73
Net Receivables	0.94	0.93	0.85	0.95		0.93	0.98	0.75	0.82	0.97	0.87	0.94	0.83	-0.58	0.4	0.66	0.9	0.46	0.7	0.86	0.37	0.58	0.92	0.85	0.87	-0.9	0.88
Total Liab	1.0	0.94	0.98	0.89	0.93		0.97	0.83	0.95	0.92	0.97	0.99	0.96	-0.56	0.57	0.55	0.97	0.17	0.89	0.79	0.64	0.68	0.81	0.97	0.96	-0.81	0.71
Total Current Assets	0.98	0.97	0.91	0.96	0.98	0.97		0.8	0.88	0.98	0.91	0.97	0.89	-0.64	0.49	0.6	0.93	0.32	0.78	0.83	0.48	0.63	0.86	0.89	0.91	-0.84	0.78
Short Term Debt	0.83	0.78	0.84	0.8	0.75	0.83	0.8		0.76	0.78	0.76	0.8	0.75	-0.6	0.55	0.55	0.78	-0.03	0.71	0.69	0.48	0.95	0.57	0.77	0.78	-0.73	0.52
Intangible Assets	0.95	0.9	0.98	0.82	0.82	0.95	0.88	0.76		0.81	0.93	0.96	0.99	-0.58	0.62	0.55	0.91	-0.07	0.94	0.73	0.79	0.66	0.62	0.94	0.89	-0.64	0.53
Accounts Payable	0.94	0.94	0.84	0.99	0.97	0.92	0.98	0.78	0.81		0.83	0.93	0.83	-0.71	0.46	0.59	0.86	0.4	0.71	0.86	0.36	0.62	0.85	0.81	0.84	-0.82	0.79
Common Stock	0.96	0.89	0.96	0.78	0.87	0.97	0.91	0.76	0.93	0.83		0.95	0.94	-0.39	0.52	0.45	0.99	0.15	0.89	0.68	0.66	0.6	0.8	1.0	0.99	-0.78	0.68
Good Will	0.99	0.96	0.97	0.92	0.94	0.99	0.97	0.8	0.96	0.93	0.95		0.96	-0.6	0.56	0.61	0.95	0.17	0.87	0.82	0.63	0.66	0.79	0.95	0.93	-0.79	0.71
Long Term Debt	0.95	0.87	0.98	0.82	0.83	0.96	0.89	0.75	0.99	0.83	0.94	0.96		-0.58	0.61	0.5	0.92	-0.03	0.95	0.75	0.77	0.65	0.65	0.95	0.9	-0.65	0.56
Treasury Stock	-0.58	-0.6	-0.55	-0.79	-0.58	-0.56	-0.64	-0.6	-0.58	-0.71	-0.39	-0.6	-0.58		-0.44	-0.39	-0.39	0.02	-0.53	-0.74	-0.26	-0.61	-0.26	-0.38	-0.39	0.28	-0.24
Property Plant Equipment	0.57	0.53	0.65	0.46	0.4	0.57	0.49	0.55	0.62	0.46	0.52	0.56	0.61	-0.44		0.27	0.46	-0.24	0.65	0.46	0.57	0.47	0.21	0.54	0.49	-0.28	0.1
Current Deferred Revenue	0.58	0.66	0.53	0.66	0.66	0.55	0.6	0.55	0.55	0.59	0.45	0.61	0.5	-0.39	0.27		0.51	0.13	0.33	0.65	0.34	0.47	0.51	0.48	0.45	-0.7	0.58
Short Term Investments	0.97	0.91	0.95	0.81	0.9	0.97	0.93	0.78	0.91	0.86	0.99	0.95	0.92	-0.39	0.46	0.51		0.2	0.85	0.71	0.62	0.62	0.84	0.99	0.99	-0.84	0.74
Net Tangible Assets	0.19	0.24	-0.01	0.31	0.46	0.17	0.32	-0.03	-0.07	0.4	0.15	0.17	-0.03	0.02	-0.24	0.13	0.2		-0.18	0.26	-0.54	-0.22	0.68	0.09	0.18	-0.49	0.7
Long Term Debt Total	0.87	0.77	0.93	0.69	0.7	0.89	0.78	0.71	0.94	0.71	0.89	0.87	0.95	-0.53	0.65	0.33	0.85	-0.18		0.71	0.79	0.63	0.51	0.91	0.87	-0.52	0.34
Capital Surpluse	0.79	0.78	0.75	0.88	0.86	0.79	0.83	0.69	0.73	0.86	0.68	0.82	0.75	-0.74	0.46	0.65	0.71	0.26	0.71		0.32	0.6	0.67	0.69	0.7	-0.71	0.57
Deferred Long Term Liab	0.62	0.53	0.75	0.38	0.37	0.64	0.48	0.48	0.79	0.36	0.66	0.63	0.77	-0.26	0.57	0.34	0.62	-0.54	0.79	0.32		0.45	0.18	0.7	0.61	-0.27	0.11
Short Long Term Debt	0.67	0.61	0.73	0.67	0.58	0.68	0.63	0.95	0.66	0.62	0.6	0.66	0.65	-0.61	0.47	0.47	0.62	-0.22	0.63	0.6	0.45		0.35	0.62	0.62	-0.55	0.33
Cash And Equivalents	0.81	0.8	0.69	0.77	0.92	0.81	0.86	0.57	0.62	0.85	0.8	0.79	0.65	-0.26	0.21	0.51	0.84	0.68	0.51	0.67	0.18	0.35		0.77	0.82	-0.93	0.94
Net Invested Capital	0.96	0.88	0.97	0.77	0.85	0.97	0.89	0.77	0.94	0.81	1.0	0.95	0.95	-0.38	0.54	0.48	0.99	0.09	0.91	0.69	0.7	0.62	0.77		0.98	-0.78	0.65
Long Term Investments	0.96	0.9	0.93	0.79	0.87	0.96	0.91	0.78	0.89	0.84	0.99	0.93	0.9	-0.39	0.49	0.45	0.99	0.18	0.87	0.7	0.61	0.62	0.82	0.98		-0.82	0.68
Net Working Capital	-0.82	-0.81	-0.73	-0.78	-0.9	-0.81	-0.84	-0.73	-0.64	-0.82	-0.78	-0.79	-0.65	0.28	-0.28	-0.7	-0.84	-0.49	-0.52	-0.71	-0.27	-0.55	-0.93	-0.78	-0.82		-0.89
Capital Stock	0.72	0.72	0.6	0.73	0.88	0.71	0.78	0.52	0.53	0.79	0.68	0.71	0.56	-0.24	0.1	0.58	0.74	0.7	0.34	0.57	0.11	0.33	0.94	0.65	0.68	-0.89

Click cells to compare fundamentals

CVS Price To Book Historical Pattern

Today, most investors in CVS Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CVS Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CVS Health price to book as a starting point in their analysis.

CVS Health Price To Book

Timeline

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Competition

Predict CVS Health

Price Book Value Ratio Over Time

CVS Book Value Per Share

Book Value Per Share

62.62

At this time, CVS Health's Book Value Per Share is comparatively stable compared to the past year.

Based on the latest financial disclosure, CVS Health Corp has a Price To Book of 0.9543 times. This is 96.28% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to book for all United States stocks is 89.97% higher than that of the company.

CVS Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.

CVS Health is currently under evaluation in price to book category among its peers.

CVS Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CVS Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CVS Health's managers, analysts, and investors.

Environmental

Governance

Social

CVS Fundamentals

	Return On Equity	0.067
	Return On Asset	0.0237
	Profit Margin	0.01 %
	Operating Margin	0.02 %
	Current Valuation	144.54 B
	Shares Outstanding	1.26 B
	Shares Owned By Insiders	0.11 %
	Shares Owned By Institutions	82.75 %
	Number Of Shares Shorted	21.85 M
	Price To Earning	42.99 X
	Price To Book	0.95 X
	Price To Sales	0.19 X
	Revenue	357.78 B
	Gross Profit	53.46 B
	EBITDA	13.74 B
	Net Income	8.37 B
	Cash And Equivalents	12.95 B
	Cash Per Share	15.21 X
	Total Debt	79.39 B
	Debt To Equity	1.00 %
	Current Ratio	0.94 X
	Book Value Per Share	59.57 X
	Cash Flow From Operations	13.43 B
	Short Ratio	1.65 X
	Earnings Per Share	3.94 X
	Price To Earnings To Growth	1.96 X
	Target Price	68.38
	Number Of Employees	219 K
	Beta	0.54
	Market Capitalization	71.52 B
	Total Asset	249.73 B
	Retained Earnings	61.6 B
	Working Capital	(11.33 B)
	Current Asset	30.38 B
	Current Liabilities	23.17 B
	Annual Yield	0.05 %
	Five Year Return	2.81 %
	Net Asset	249.73 B
	Last Dividend Paid	2.6

About CVS Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC